NID2 (nidogen 2)

2007-05-01  

Identity

HGNC
LOCATION
14q22.1
LOCUSID
ALIAS
NID-2
FUSION GENES

Other Information

Locus ID:

NCBI: 22795
MIM: 605399
HGNC: 13389
Ensembl: ENSG00000087303

Variants:

dbSNP: 22795
ClinVar: 22795
TCGA: ENSG00000087303
COSMIC: NID2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000087303ENST00000216286Q14112
ENSG00000087303ENST00000556572H0YJV3
ENSG00000087303ENST00000617139A0A087WZP6

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Extracellular matrix organizationREACTOMER-HSA-1474244
Laminin interactionsREACTOMER-HSA-3000157

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
345936722022Nidogen-2: A new biomarker in colon cancer patients.1
345936722022Nidogen-2: A new biomarker in colon cancer patients.1
337581602021Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.11
343152242021Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling.19
337581602021Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.11
343152242021Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling.19
308269722020Silencing NID2 by DNA Hypermethylation Promotes Lung Cancer.9
321712892020Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma.10
324721132020A pilot proteomic study with a prospective cohort suspected to develop preeclampsia.0
308269722020Silencing NID2 by DNA Hypermethylation Promotes Lung Cancer.9
321712892020Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma.10
324721132020A pilot proteomic study with a prospective cohort suspected to develop preeclampsia.0
309754892019Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.16
313628882019NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.13
309754892019Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.16

Citation

Dessen P

NID2 (nidogen 2)

Atlas Genet Cytogenet Oncol Haematol. 2007-05-01

Online version: http://atlasgeneticsoncology.org/gene/47531/haematological-explorer/js/js/lib/zoomerang.js